ENTITY

Crystalgenomics Inc (083790 KS)

Analysis

Health Care • South Korea

CrystalGenomics Incorporation develops pharmaceutical and agricultural products by structure-based drug discovery technology. The Company also provides structural proteomic analysis services for helping drug discovery process.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00